JP
Insider selling
Jason P Rhodes sold $17.9M of Dyne Therapeutics, Inc. (DYN) stock
Jason P Rhodes, Dir of Dyne Therapeutics, Inc. (DYN), sold 777,451 shares of DYN stock worth $17.9M, per an SEC Form 4 filed Jul 8, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jul 6, 2026, 2 days before it was made public.
DYN has moved -25.0% since the trade date, from $22.84 to $17.12 (Sep 21, 2026 close).
- Traded
- Jul 6, 2026
- Disclosed
- Jul 8, 2026
- Filing delay
- 2 days
- Price since
- -25.0%
- Role
- Dir
- Source
- SEC Form 4
More DYN insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.